Document is current

Article History

Accepted: 1 May 2023

First Online: 9 May 2023

Declarations

:

: Dr. Arshi has no conflicts of interest to declare. Dr. Hughes has no conflicts of interest to declare. Dr. Robin has no conflicts of interest to declare. Dr. Parvizi declares the following potential conflicts of interest: 3 M: research support; Acumed, LLC: stock or stock options; Aesculap: research support; Alphaeon: stock or stock options; AO Spine: research support; Becton Dickenson: IP royalties; paid consultant; Biomet: research support; Cardinal Health: paid consultant; Cempra: research support; CeramTec: research support; Ceribell: stock or stock options; Coracoid: stock or stock options; Corentec: IP royalties; paid consultant; Datatrace: publishing royalties, financial or material support; DePuy: research support; Elsevier: publishing royalties, financial or material support; Elute: stock or stock options; Ethicon: paid consultant; Hip Innovation Technology: stock or stock options; Illuminus: stock or stock options; Integra: research support; Intellijoint: stock or stock options; Jaypee Publishers: publishing royalties, financial or material support; KCI/3 M (Acelity): paid consultant; Lima: research support; MicroGenDx: paid consultant; Molecular Surface Technologies: stock or stock options; Myoscience: research support; Nanooxygenic: stock or stock options; National Institutes of Health (NIAMS & NICHD): research support; NDRI: research support; Novartis: research support; OREF: research support; Orthospace: research support; Osteal: stock or stock options; Parvizi Surgical Innovations and Subsidiaries: stock or stock options; Peptilogic: stock or stock options; Peptilogics: paid consultant; Pfizer: research support; PRN-Veterinary: stock or stock options; Rotation Medical: research support; Simplify Medical: research support; SLACK Incorporated: publishing royalties, financial or material support; Smith & Nephew: research support; Sonata: stock or stock options; Stelkast: research support; Stryker: research support; Synthes: research support; Tenor: paid consultant; TissueGene: research support; Tornier: research support; Wolters Kluwer Health-Lippincott Williams & Wilkins: publishing royalties, financial or material support; Zimmer Biomet: paid consultant; research support. Dr. Fillingham declares the following potential conflicts of interest: board or committee member; American Association of Hip and Knee Surgeons: board or committee member; Exactech, Inc: IP royalties; paid consultant; Johnson & Johnson: paid consultant; Medacta: IP royalties; paid consultant; MicroGen Dx: other financial or material support; Parvizi Surgical Innovations: stock or stock options; Saunders/Mosby-Elsevier: publishing royalties, financial or material support; Zimmer: paid consultant.

: This article does not contain any studies with human participants or animals performed by any of the authors.